Read the full post at Biopact.
Researchers at Sweden’s Karolinska Institute and at the Royal Veterinary College (RVC) in London have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of industrial and medical products. The method involves safer, less costly alternatives and is well suited for industrial production of many types of biofuels and biopharmaceuticals. The research has been published as an open access article in BMC Biotechnology.
